Abstract

Axillary surgery is an important part of the treatment of breast cancer . It is critical to the staging of disease, prescription of adjuvant therapy and prognosis. Sentinel lymph node biopsy is a safe and accurate minimally invasive method for detecting axillary lymph node involvement. Axillary lymph node dissection can be avoided in many situations without oncologic impairment. The management of the axilla in the presence of isolated tumor cells, micrometastases and even in some cases of macrometastases in sentinel lymph node biopsy is controversial. We discuss the evolution of axillary surgery in breast cancer, the management of the axilla after sentinel lymph node biopsy and the best axillary approach for each patient.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call